REGONAT-REGORAFENIB TABLETS

Get a Price/Quote

MOQ : 1 Bottle

REGONAT-REGORAFENIB TABLETS Specification

Drug Type
Other Types

Ingredients
REGORAFENIB

Physical Form
Tablets

Function
Anti-Radiation

Dosage
40MG

REGONAT-REGORAFENIB TABLETS Trade Information

Minimum Order Quantity
1 Bottle

Packaging Details
PACK OF 28 TABLETS

Main Domestic Market
All India

Certifications
brand name - regonat form- tablets manufacturer by - natco

About REGONAT-REGORAFENIB TABLETS

REGONAT

Specifications:-

Brand Name :- REGONAT
Content:- Regorafenib
Strength: 40 mg
Form:- Tablets
Packing:- Pack of 28 Tablets
Manufactured By :- NATCO

Note:- Regonat Is A Prescription Drug and Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug............

Key Features

REGONAT-Regorafenib Tablets are presented in a convenient tablet form, each containing 40mg of the active ingredient Regorafenib. Their anti-radiation properties make them valuable in oncology treatments, particularly in cases that demand adjunct support to radiation therapy. Sourced from India, these tablets are distributed through reputable channels, ensuring accessibility and compliance with international standards.

Usage and Administration

The dosing of REGONAT-Regorafenib Tablets should be strictly supervised by healthcare professionals. The 40mg dosage may be adjusted based on individual patient needs and treatment protocols. Its crucial for patients to adhere to prescribed schedules and report any side effects to ensure optimal benefit during their cancer management journey.

FAQs of REGONAT-REGORAFENIB TABLETS:

Q: How do REGONAT-Regorafenib Tablets function as anti-radiation medication?

A: REGONAT-Regorafenib Tablets act as anti-radiation support by inhibiting multiple protein kinases involved in tumor growth and angiogenesis, thereby enhancing the effects of radiation therapy and potentially improving therapeutic outcomes in cancer treatments.

Q: What is the main ingredient in REGONAT-Regorafenib Tablets and its significance?

A: The main component is Regorafenib, a multi-kinase inhibitor known for its efficacy in oncology. This ingredient helps manage certain cancers by blocking pathways that promote tumor progression, offering valuable anti-radiation benefits.

Q: When should REGONAT-Regorafenib Tablets be administered during a treatment regimen?

A: Administration timing depends on the treatment plan devised by a medical professional. Typically, REGONAT is integrated into specific cycles of cancer therapy and adjusted according to the patients response and overall health condition.

Q: Where can REGONAT-Regorafenib Tablets be sourced by distributors and medical suppliers?

A: REGONAT-Regorafenib Tablets can be sourced through authorized distributors, exporters, suppliers, traders, and wholesalers in India, who ensure adherence to pharmaceutical guidelines and global standards.

Q: What is the process for exporting REGONAT-Regorafenib Tablets internationally?

A: Exporting REGONAT-Regorafenib Tablets involves coordination with certified Indian wholesalers and suppliers, compliance with regulatory documentation, and observation of international shipping protocols to guarantee product quality and safe delivery.

Q: How should patients use REGONAT-Regorafenib Tablets for optimal results?

A: Patients must use REGONAT-Regorafenib Tablets strictly according to a physicians prescription. Regular monitoring and medical supervision ensure correct dosage while minimizing potential side effects and maximizing treatment benefits.

Q: What are the primary benefits of using REGONAT-Regorafenib Tablets in cancer care?

A: REGONAT-Regorafenib Tablets can improve treatment outcomes by helping to inhibit tumor growth, support the efficacy of radiation therapy, and offer manageable oral dosing, contributing to patient quality of life during cancer management.

Tell us about your requirement